<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药智网 | wechat-feeds</title><link>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</link><description>让药物创造变得容易！我们致力于成为中国健康产业的传播者、服务者、推动者。</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 29 Jan 2021 11:37:23 +0800</pubDate><image><url>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</url><title>药智网 | wechat-feeds</title><link>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>国务院发文：集采常态化，应采尽采！2021带量采购价格裸奔时代到来？</title><link>https://mp.weixin.qq.com/s/y2MpCIBcDbjk-PTH82lD2g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VODicD3NgNo3Zic2NnSlVUIet6j3YzbXRa1wphs6nqO2JU7bNfcDiaNTzNVuicIWEVibUH2UBibzYvvAP4g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>原创深度：六点全面解读国办药品带量采购新规！]]></content:encoded><pubDate>Fri, 29 Jan 2021 11:12:52 +0800</pubDate></item><item><title>破•局｜药企如何利用知识产权，走出专利纠纷困境？</title><link>https://mp.weixin.qq.com/s/Naygon9o3JzlK438fWFGog</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VODicD3NgNo3Zic2NnSlVUIetDlg1KVAD45NyJGSIpaN73GytqicvWUEg19bklBrblbl9mSDDR60HX3Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>如何抢占先机？]]></content:encoded><pubDate>Fri, 29 Jan 2021 11:12:52 +0800</pubDate></item><item><title>2020年片仔癀营收、净利增长，转型看齐“云南白药”</title><link>https://mp.weixin.qq.com/s/z67mUvaX79pSux7fT5Ix3w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VODicD3NgNo3Zic2NnSlVUIetys50Zz4Vrsg31l2mPZE53qo5wNjaqveywics99OAbqAvoZN54b5uLIA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>产品“涨价”不如营收多元化，片仔癀转型之路或更有价值。]]></content:encoded><pubDate>Fri, 29 Jan 2021 11:12:52 +0800</pubDate></item><item><title>中国成人血脂异常率高达40.40%，降脂策略有哪些？</title><link>https://mp.weixin.qq.com/s/OljRSERWQupI-925zFC0TQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VODicD3NgNo3Zic2NnSlVUIetPXciaZ6spxWMTrP5Ss4picL3B11Zbwdv29icduDPicI6ouYvVn60GwQmHQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>如何调节血脂异常？]]></content:encoded><pubDate>Fri, 29 Jan 2021 11:12:52 +0800</pubDate></item><item><title>2020盘点：1500亿美元抗体药物市场竞争加剧，国内创新药企迅速崛起，恒瑞、君实、信达…</title><link>https://mp.weixin.qq.com/s/6TMr7trpRFJKm01Jiavf6Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VPVNxcp7oB7aIMiaWGuxpHiavLvk0PRshHeQSWr1xdSN6diaTBWpBoWkdwxg759Lx42n6cAXQy2a3DSg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>双抗和ADC药物成新的热门领域。]]></content:encoded><pubDate>Thu, 28 Jan 2021 16:29:08 +0800</pubDate></item><item><title>专利未到期，辉瑞60亿美元级明星药价格腰斩！CDK4/6抑制剂国内竞争几何？</title><link>https://mp.weixin.qq.com/s/RKWnMR2lDPNelfm8t3-d9g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VPVNxcp7oB7aIMiaWGuxpHiavmic5PI6CUNuB00Z4opCFvyuGwsy9JcQmtpCmrfBjqkVIsw7KT6fxjKg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>恒瑞创新研发最快，齐鲁首仿上市获批！]]></content:encoded><pubDate>Thu, 28 Jan 2021 16:29:08 +0800</pubDate></item><item><title>千亿蓝海大市场，谁是癌症早筛第一股？</title><link>https://mp.weixin.qq.com/s/qYYCl-ITalr7MX2SGL9KqQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VM6pZnf4HdOice0dPNgpjnxdn48WzBA6fwkbyGaG3PIOoqTNwhNl3NiaKWpjoiajXopJ0IrySZPl8b3Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>还没有被航行过，每一艘船都刚出发]]></content:encoded><pubDate>Thu, 28 Jan 2021 16:29:08 +0800</pubDate></item><item><title>药企带量采购应对：是否会被纳入集采？该做哪些工作？</title><link>https://mp.weixin.qq.com/s/pB0z5eAyG4ejChKW1_YZ5w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VPVNxcp7oB7aIMiaWGuxpHiavtII1Q3IYobzJiafCGicUUC04ybnqIlCibULw5hRJSvYSflnqdaXhJDaUA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>回到集采层面，药企还有什么具体的应对方式？]]></content:encoded><pubDate>Thu, 28 Jan 2021 16:29:08 +0800</pubDate></item><item><title>2020盘点：临床试验失败案例TOP10！罗氏最多，阿斯利康、赛诺菲、GSK......</title><link>https://mp.weixin.qq.com/s/DNt2yvh6aJGZ6TCA4UFYPg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VM6pZnf4HdOice0dPNgpjnxdGT4ibKfGOm5sic320RUCs76BJ00KxPaBCYiaqnvicD2DtDL5YpxIdttibhw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>羟氯喹组针对COVID-19研究失败企业最多。]]></content:encoded><pubDate>Wed, 27 Jan 2021 16:45:01 +0800</pubDate></item><item><title>医药企业“专利之争”不绝于耳，“大小”迈瑞这对“冤家”最典型！</title><link>https://mp.weixin.qq.com/s/PFlskWolkWApDdjDpRIuZA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VM6pZnf4HdOice0dPNgpjnxdWnn8icNJl7kwica4T03pHUelFb8EPTibfc19vS4TicoTGX8aoteIn5KTAg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>理邦仪器：与迈瑞医疗相差56个“理邦”]]></content:encoded><pubDate>Wed, 27 Jan 2021 16:45:01 +0800</pubDate></item><item><title>【转发抽奖】您的药智数据VIP，我们包了！</title><link>https://mp.weixin.qq.com/s/wdpqTIj13t47lM2t_x2Gvw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VM6pZnf4HdOice0dPNgpjnxdHKRUIzeSZjJcbWEwwN1rufhFcYc4ObkfIUiaT89XzhU8fYzU359Lgrg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>【转发抽奖】承包您1整年的药智数据VIP，新年许愿入选精选留言100%中奖]]></content:encoded><pubDate>Wed, 27 Jan 2021 16:45:01 +0800</pubDate></item><item><title>2021年，这个领域将大量招人</title><link>https://mp.weixin.qq.com/s/lfkU2DedZRSwpZmcb3E_lQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VM6pZnf4HdOice0dPNgpjnxdjmPO9KT77OOTAmibXCtrAxFepPCDYysIibuNgO7mMVFpribUL0p2q2Diag/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药人在互联网领域破圈找更多机会。]]></content:encoded><pubDate>Wed, 27 Jan 2021 16:45:01 +0800</pubDate></item><item><title>2020医药三大榜：重复率超60%，39家企业“三榜同入”，独榜企业特点是？</title><link>https://mp.weixin.qq.com/s/oXu6KA0p6G7l7_mxB_5oTQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VOfSrr363TpJicaiciaWIq4OAqIXibEDdfb9NnnaaOyeQeLd8bibGjJRZ6g01nV8xQRwZotZYCn38Lb64w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>独榜企业差异“巨大”]]></content:encoded><pubDate>Tue, 26 Jan 2021 16:44:23 +0800</pubDate></item><item><title>专家分享：18年临床研发经验，让医药人快速进入角色</title><link>https://mp.weixin.qq.com/s/jAF5Awiu1KhkogtF13tP7Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VOfSrr363TpJicaiciaWIq4OAqL9JLUcU4Jony5aJpq5jfNpcn8uY15CdRHiaBzfZicCWicibbUb7VVZecVw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>第一篇：职业能力。]]></content:encoded><pubDate>Tue, 26 Jan 2021 16:44:23 +0800</pubDate></item><item><title>中纪委开会，定调医疗反腐</title><link>https://mp.weixin.qq.com/s/aMP2mV70DUVNc7dWSTJeVA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VOfSrr363TpJicaiciaWIq4OAqRibMMTuMrPMIKqEcbrbEetKFibtaKGvlHhejHEZg1ibVIqQBXusicbStSQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>中纪委开会，部署2021年任务，医疗反腐仍是重点]]></content:encoded><pubDate>Tue, 26 Jan 2021 16:44:23 +0800</pubDate></item><item><title>超10万只！多家企业紧急召回不合格口罩，快自查</title><link>https://mp.weixin.qq.com/s/JrdaIVtowRzk7kOrH3KiiA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VOfSrr363TpJicaiciaWIq4OAqiaB83p0x0icG2HXtt0ywmBaiaPxiaibzLJeicTtNVKGBdzqXLgHCibT1LncDA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>来源：中国市场监管报由于防疫需要口罩成了每家每户的必备物资作为疫情期间的“防护标配”口罩的质量一直受到大家的]]></content:encoded><pubDate>Tue, 26 Jan 2021 16:44:23 +0800</pubDate></item><item><title>自身免疫性疾病患病率逐年增加，2025年市场规模或将达1522亿美元！</title><link>https://mp.weixin.qq.com/s/y0q7Qure4ovmDr4Btk6h0Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VPDrgaxeaVpx1oGNMFfxYVD7coFddwiaAsAMIqDfrbf9Blk9Y1HZ7ws4zKru9MryfGIYKqic13QoPIw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>自身免疫疾病治疗药物市场分析。]]></content:encoded><pubDate>Mon, 25 Jan 2021 15:59:33 +0800</pubDate></item><item><title>最新调查：63.5%的医药人，想辞职</title><link>https://mp.weixin.qq.com/s/EFP4UYQVVhI94kaRuz2JJg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VPDrgaxeaVpx1oGNMFfxYVDppnWbID8wtxe27yQURkWk14fts0VgtornTCjMM26XicKLuZOWRf9TTw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>过一半的医药人表示，如果有机会，他们想辞职]]></content:encoded><pubDate>Mon, 25 Jan 2021 15:59:33 +0800</pubDate></item><item><title>CD123靶向药物Elzonris在欧盟获批 治疗罕见血液恶性肿瘤</title><link>https://mp.weixin.qq.com/s/inWfSMqa6dydKOJdG_pwsw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VPDrgaxeaVpx1oGNMFfxYVDaxPbSyn8ARjdqBB5SkMgQhg5KhNmK9kx009rzAIl1x0hbmqq3BnuYg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Elzonris成欧洲首个获批BPDCN治疗药物，也是首个CD123靶向疗法。]]></content:encoded><pubDate>Mon, 25 Jan 2021 15:59:33 +0800</pubDate></item><item><title>【药咖君】我武生物黄花蒿粉滴剂上市在即！百济神州引进新药申报上市，信立泰、齐鲁…</title><link>https://mp.weixin.qq.com/s/V69FJziHVcMEG7Pye8rj9w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VPLGeibJibKeURz1xu4Fv4DD7ljficrjnumEWEM77lyetSHJxZ6yT1X3h2ILbbGhk2rFKibDWH7ibGWp3Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>最新CDE药审动态。]]></content:encoded><pubDate>Sun, 24 Jan 2021 09:55:12 +0800</pubDate></item></channel></rss>